Literature DB >> 3341550

Effect of cyclosporin A on hepatocyte proliferation after partial hepatectomy in rats: comparison with standard immunosuppressive agents.

Y I Kim1, P Salvini, F Auxilia, R Y Calne.   

Abstract

The effects of cyclosporin A on the regenerating liver were studied in rats after partial hepatectomy and were compared with those of conventional immunosuppressants such as methylprednisolone and azathioprine. In Group I, a standard hepatectomy removing two thirds of the organ was performed. In Group II, an oral dose of 10 mg/kg of cyclosporin A was given 1 day before and immediately, 24 hours, and 48 hours after the same hepatectomy. In Groups III and IV, azathioprine and methylprednisolone were administered in 8 mg/kg doses by way of the tail vein by the same protocol as in Group II. The mortality rate, liver weight restoration, and histologic and mitotic characteristics of the liver remnants, as well as serum levels of animotransferase, total bilirubin, and creatinine were examined from 24 hours to 10 days after the operation. Azathioprine and methylprednisolone substantially suppressed hepatocyte mitosis when compared with the control group; however, cyclosporin A treatment did not inhibit, but may, in fact, have stimulated liver cell proliferation. Changes in other parameters coincided with this phenomenon. The noninhibitory effect of cyclosporin A on liver regeneration has also been discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341550     DOI: 10.1016/s0002-9610(88)80705-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.

Authors:  L Rossaro; V Mazzaferro; C L Scotti-Foglieni; D S Williams; E Simplaceanu; V Simplaceanu; A Francavilla; T E Starzl; C Ho; D H Van Thiel
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

3.  Steroid administration before partial hepatectomy with temporary inflow occlusion does not influence cyclin D1 and Ki-67 related liver regeneration.

Authors:  Matthias Glanemann; Simone Münchow; Anja Schirmeier; Hussein Al-Abadi; Frank Lippek; Jan M Langrehr; Manfred Dietel; Peter Neuhaus; Andreas K Nussler
Journal:  Langenbecks Arch Surg       Date:  2004-08-27       Impact factor: 3.445

4.  The hepatotropic influence of cyclosporine.

Authors:  V Mazzaferro; K A Porter; C L Scotti-Foglieni; R Venkataramanan; L Makowka; L Rossaro; A Francavilla; S Todo; D H Van Thiel; T E Starzl
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

5.  Cyclosporine and liver regeneration studied by in vivo 31P nuclear magnetic resonance spectroscopy.

Authors:  L Rossaro; V Mazzaferro; C L Scotti-Foglieni; K A Porter; D S Williams; E Simplaceanu; V Simplaceanu; A Francavilla; T E Starzl; C Ho
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

6.  FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.

Authors:  M F Sakr; G M Zetti; T I Hassanein; H Farghali; M A Nalesnik; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

7.  Adult-adult living donor liver transplantation.

Authors:  Masatoshi Makuuchi; Charles M Miller; Kim Olthoff; Myron Schwartz
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.